{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [
    {
      "AbstractText": [
        "Die geltende Leitlinie f\u00fcr kinderonkologische Patienten mit febriler Granulozytopenie (FN) von 2016 empfiehlt eine Time-to-Antibiotics (TTA)<60\u2009min.",
        "Kritische Analyse verf\u00fcgbarer Studien und Metaanalysen, Diskussion der Konsequenzen in der Arbeitsgruppe Fieber bei Granulozytopenie der Fachgesellschaften f\u00fcr p\u00e4diatrische Onkologie und H\u00e4matologie und p\u00e4diatrische Infektiologie.",
        "Die verf\u00fcgbaren Studien k\u00f6nnen keinen klinisch signifikanten Vorteil einer TTA<60\u2009min f\u00fcr alle kinderonkologischen Patienten mit FN darstellen. Studien, die einen solchen Zusammenhang nahelegen, sind mit einem Triage Bias und anderen methodischen Limitationen behaftet und nutzen unterschiedliche TTA Definitionen. Hingegen ist eine TTA<60\u2009min elementarer Bestandteil des Einstunden-Ma\u00dfnahme-B\u00fcndels bei septischem Schock oder Sepsis mit Organdysfunktion.",
        "Wenn alle kinderonkologischen Patienten mit neu aufgetretenem Fieber zeitnah durch gut ausgebildetes und trainiertes Fachpersonal eine strukturierte Anamnese und k\u00f6rperliche Untersuchung (inkl. Vitalzeichen) erhalten und unter der Voraussetzung, dass lokal eine Sepsis Triage und Management B\u00fcndel etabliert und implementiert wurde, ist eine TTA<3\u2009h bei kinderonkologischen Patienten mit FN angemessen."
      ],
      "CopyrightInformation": "Thieme. All rights reserved."
    }
  ],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "37751768",
  "DateCompleted": {
    "Year": "2023",
    "Month": "11",
    "Day": "13"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "11",
    "Day": "13"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2023",
        "Month": "09",
        "Day": "26"
      }
    ],
    "Language": [
      "ger"
    ],
    "ELocationID": [
      "10.1055/a-2135-4210"
    ],
    "Journal": {
      "ISSN": "1439-3824",
      "JournalIssue": {
        "Volume": "235",
        "Issue": "6",
        "PubDate": {
          "Year": "2023",
          "Month": "Nov"
        }
      },
      "Title": "Klinische Padiatrie",
      "ISOAbbreviation": "Klin Padiatr"
    },
    "ArticleTitle": "[Time to Antibiotics (TTA) - Reassessment from the German Working Group for Fever and Neutropenia in Children and Adolescents (DGPI/GPOH)].",
    "Pagination": {
      "StartPage": "331",
      "EndPage": "341",
      "MedlinePgn": "331-341"
    },
    "Abstract": {
      "AbstractText": [
        "The current German guidance from 2016 recommends a Time to Antibiotics (TTA) of<60\u2009min in children and adolescents with febrile neutropenia (FN).",
        "Critical analysis of available studies and recent meta-analyses, and discussion of the practical consequences in the FN working group of the German Societies for Paediatric Oncology and Haematology and Paediatric Infectious Diseases.",
        "The available evidence does not support a clinically significant outcome benefit of a TTA<60\u2009min in all paediatric patients with FN. Studies suggesting such a benefit are biased (mainly triage bias), use different TTA definitions and display further methodical limitations. In any case, a TTA<60\u2009min remains an essential component of the 1st hour-bundle in paediatric cancer patients with septic shock or sepsis with organ dysfunction.",
        "Provided that all paediatric FN patients receive a structured medical history and physical examination (including vital signs) by experienced and trained medical personnel in a timely fashion, and provided that a sepsis triage and management bundle is established and implemented, a TTA lower than 3\u2009hours is sufficient and reasonable in stable paediatric cancer patients with FN."
      ],
      "CopyrightInformation": "Thieme. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0001-9558-3330"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "P\u00e4diatrische Onkologie und H\u00e4matologie, Universit\u00e4tskinderklinik Homburg, Homburg, Germany."
          }
        ],
        "LastName": "Simon",
        "ForeName": "Arne",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Klinik f\u00fcr Kinder- und Jugendheilkunde, Klinikum der Johann-Wolfgang-Goethe-Universit\u00e4t, Frankfurt, Germany."
          }
        ],
        "LastName": "Lehrnbecher",
        "ForeName": "Thomas",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "P\u00e4diatrische Onkologie und H\u00e4matologie, TeleKasper Projekt, Universit\u00e4tskinderklinik Homburg, Homburg, Germany."
          }
        ],
        "LastName": "Baltaci",
        "ForeName": "Yeliz",
        "Initials": "Y"
      },
      {
        "Identifier": [
          "0000-0001-8973-5406"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Kinderklinik 1, Universit\u00e4tsklinik Essen, Essen, Germany."
          }
        ],
        "LastName": "Dohna-Schwake",
        "ForeName": "Christian",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "P\u00e4d. H\u00e4matologie und Onkologie, Univ.-Klinikum M\u00fcnster, Klinik f\u00fcr Kinder- und Jugendmedizin, M\u00fcnster, Germany."
          }
        ],
        "LastName": "Groll",
        "ForeName": "Andreas",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Klinik f\u00fcr Kinder-Onkologie, - H\u00e4matologie und - Klinische Immunologie, Universerstit\u00e4tsklinikum D\u00fcsseldorf, D\u00fcsseldorf, Germany."
          }
        ],
        "LastName": "Laws",
        "ForeName": "Hans-J\u00fcrgen",
        "Initials": "HJ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "P\u00e4diatrische Onkologie und H\u00e4matologie, Universit\u00e4tskinderklinik M\u00fcnster, Muenster, Germany."
          }
        ],
        "LastName": "Potratz",
        "ForeName": "Jenny",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Klinik f\u00fcr Kinderheilkunde und Jugendmedizin, Universit\u00e4tskinderklinik Freiburg, Freiburg, Germany."
          }
        ],
        "LastName": "Hufnagel",
        "ForeName": "Markus",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "P\u00e4diatrische H\u00e4matologie und Onkologie, Universit\u00e4tsklinik Frankfurt, Frankfurt, Germany."
          }
        ],
        "LastName": "Bochennek",
        "ForeName": "Konrad",
        "Initials": "K"
      }
    ],
    "PublicationTypeList": [
      "English Abstract",
      "Journal Article"
    ],
    "VernacularTitle": "Time to Antibiotics (TTA) \u2013 \u00dcberlegungen der Arbeitsgruppe Fieber bei Granulozytopenie im Kindes- und Jugendalter (GPOH/DGPI) zu einer Neubewertung."
  },
  "MedlineJournalInfo": {
    "Country": "Germany",
    "MedlineTA": "Klin Padiatr",
    "NlmUniqueID": "0326144",
    "ISSNLinking": "0300-8630"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Bacterial Agents"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Child"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Adolescent"
    },
    {
      "QualifierName": [
        "adverse effects"
      ],
      "DescriptorName": "Anti-Bacterial Agents"
    },
    {
      "QualifierName": [
        "chemically induced",
        "diagnosis",
        "drug therapy"
      ],
      "DescriptorName": "Neutropenia"
    },
    {
      "QualifierName": [
        "diagnosis",
        "drug therapy",
        "etiology"
      ],
      "DescriptorName": "Fever"
    },
    {
      "QualifierName": [
        "complications",
        "drug therapy"
      ],
      "DescriptorName": "Neoplasms"
    },
    {
      "QualifierName": [
        "diagnosis",
        "drug therapy"
      ],
      "DescriptorName": "Shock, Septic"
    }
  ],
  "CoiStatement": "Die Autorinnen/Autoren geben an, dass kein Interessenkonflikt besteht."
}